

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 5.87215094 |
| 2 | cellular extravasation (GO:0045123) | 5.36936441 |
| 3 | piRNA metabolic process (GO:0034587) | 4.53614462 |
| 4 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.34940514 |
| 5 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.33392912 |
| 6 | histone H3-K4 trimethylation (GO:0080182) | 4.04290755 |
| 7 | mannose metabolic process (GO:0006013) | 3.73523968 |
| 8 | histone H3-K9 demethylation (GO:0033169) | 3.57898458 |
| 9 | carnitine transmembrane transport (GO:1902603) | 3.46598093 |
| 10 | DNA methylation involved in gamete generation (GO:0043046) | 3.43722613 |
| 11 | positive regulation of extracellular matrix organization (GO:1903055) | 3.31687704 |
| 12 | amino-acid betaine transport (GO:0015838) | 3.29857786 |
| 13 | carnitine transport (GO:0015879) | 3.29857786 |
| 14 | cyclic nucleotide catabolic process (GO:0009214) | 3.26732613 |
| 15 | cAMP catabolic process (GO:0006198) | 3.26175207 |
| 16 | histone H3-K36 demethylation (GO:0070544) | 3.23439187 |
| 17 | peptidyl-lysine trimethylation (GO:0018023) | 3.22327193 |
| 18 | exocrine pancreas development (GO:0031017) | 3.18462560 |
| 19 | ER overload response (GO:0006983) | 3.15079200 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12383044 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 3.11421011 |
| 22 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.08234789 |
| 23 | auditory behavior (GO:0031223) | 3.05373697 |
| 24 | relaxation of cardiac muscle (GO:0055119) | 3.01224299 |
| 25 | regulation of beta-amyloid formation (GO:1902003) | 2.98082196 |
| 26 | phospholipid dephosphorylation (GO:0046839) | 2.97774403 |
| 27 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.97326850 |
| 28 | microglial cell activation (GO:0001774) | 2.96366807 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 2.95423700 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 2.95423700 |
| 31 | negative regulation of complement activation (GO:0045916) | 2.94285598 |
| 32 | negative regulation of protein activation cascade (GO:2000258) | 2.93868777 |
| 33 | regulation of protein kinase A signaling (GO:0010738) | 2.93305099 |
| 34 | negative regulation of interleukin-8 production (GO:0032717) | 2.93241643 |
| 35 | detection of molecule of bacterial origin (GO:0032490) | 2.88747910 |
| 36 | COPII vesicle coating (GO:0048208) | 2.87402068 |
| 37 | Golgi to plasma membrane protein transport (GO:0043001) | 2.86617774 |
| 38 | histone deubiquitination (GO:0016578) | 2.86164432 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.85518708 |
| 40 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.85277119 |
| 41 | mechanosensory behavior (GO:0007638) | 2.84360443 |
| 42 | astrocyte differentiation (GO:0048708) | 2.84344196 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83520793 |
| 44 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.81684787 |
| 45 | eye photoreceptor cell differentiation (GO:0001754) | 2.77687614 |
| 46 | photoreceptor cell differentiation (GO:0046530) | 2.77687614 |
| 47 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77436654 |
| 48 | interkinetic nuclear migration (GO:0022027) | 2.76258357 |
| 49 | Golgi to endosome transport (GO:0006895) | 2.76176200 |
| 50 | cellular response to ethanol (GO:0071361) | 2.74413175 |
| 51 | response to auditory stimulus (GO:0010996) | 2.74318629 |
| 52 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.73774679 |
| 53 | * establishment of protein localization to Golgi (GO:0072600) | 2.73706086 |
| 54 | * protein targeting to Golgi (GO:0000042) | 2.72868674 |
| 55 | Golgi to plasma membrane transport (GO:0006893) | 2.71291940 |
| 56 | negative regulation of humoral immune response (GO:0002921) | 2.70156612 |
| 57 | alanine transport (GO:0032328) | 2.69082549 |
| 58 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.67193277 |
| 59 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.66466732 |
| 60 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66156402 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.65506182 |
| 62 | neutrophil mediated immunity (GO:0002446) | 2.63415882 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61531289 |
| 64 | synaptic vesicle maturation (GO:0016188) | 2.61456787 |
| 65 | hypotonic response (GO:0006971) | 2.60162212 |
| 66 | regulation of ARF GTPase activity (GO:0032312) | 2.59018148 |
| 67 | nucleotide transmembrane transport (GO:1901679) | 2.58437785 |
| 68 | long-term synaptic potentiation (GO:0060291) | 2.56950383 |
| 69 | cellular potassium ion homeostasis (GO:0030007) | 2.56572172 |
| 70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56229086 |
| 71 | regulation of histone H3-K27 methylation (GO:0061085) | 2.56076357 |
| 72 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.55618716 |
| 73 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.55045279 |
| 74 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.54686045 |
| 75 | locomotory exploration behavior (GO:0035641) | 2.54040966 |
| 76 | synaptonemal complex assembly (GO:0007130) | 2.53778065 |
| 77 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.52590524 |
| 78 | embryonic process involved in female pregnancy (GO:0060136) | 2.50479814 |
| 79 | detection of calcium ion (GO:0005513) | 2.49975302 |
| 80 | neuron cell-cell adhesion (GO:0007158) | 2.49657493 |
| 81 | cAMP metabolic process (GO:0046058) | 2.48936314 |
| 82 | dendrite morphogenesis (GO:0048813) | 2.47869979 |
| 83 | histone lysine demethylation (GO:0070076) | 2.47616658 |
| 84 | sphingosine metabolic process (GO:0006670) | 2.46745827 |
| 85 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.46591712 |
| 86 | cholesterol efflux (GO:0033344) | 2.45686661 |
| 87 | lactate metabolic process (GO:0006089) | 2.45646241 |
| 88 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45594893 |
| 89 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.44990191 |
| 90 | skeletal muscle adaptation (GO:0043501) | 2.44950973 |
| 91 | intestinal absorption (GO:0050892) | 2.44834742 |
| 92 | macroautophagy (GO:0016236) | 2.44792179 |
| 93 | presynaptic membrane assembly (GO:0097105) | 2.44012829 |
| 94 | synaptic vesicle exocytosis (GO:0016079) | 2.43902427 |
| 95 | vitamin transmembrane transport (GO:0035461) | 2.43328210 |
| 96 | membrane repolarization during action potential (GO:0086011) | 2.42570143 |
| 97 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41644083 |
| 98 | innervation (GO:0060384) | 2.41079397 |
| 99 | muscle atrophy (GO:0014889) | 2.40216662 |
| 100 | startle response (GO:0001964) | 2.40045199 |
| 101 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.39993987 |
| 102 | detection of light stimulus involved in visual perception (GO:0050908) | 2.39993987 |
| 103 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.39985132 |
| 104 | auditory receptor cell differentiation (GO:0042491) | 2.39608909 |
| 105 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.39562241 |
| 106 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.39036476 |
| 107 | striated muscle atrophy (GO:0014891) | 2.37551944 |
| 108 | quaternary ammonium group transport (GO:0015697) | 2.37299658 |
| 109 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.36968337 |
| 110 | activation of protein kinase A activity (GO:0034199) | 2.36732679 |
| 111 | regulation of complement activation (GO:0030449) | 2.36536079 |
| 112 | positive regulation of dendritic spine development (GO:0060999) | 2.35787964 |
| 113 | Golgi organization (GO:0007030) | 2.35331464 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.34836513 |
| 115 | vesicle coating (GO:0006901) | 2.34270051 |
| 116 | * retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.33199243 |
| 117 | histone demethylation (GO:0016577) | 2.33039146 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 2.32314880 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 2.32314880 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.32314880 |
| 121 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.32314880 |
| 122 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.32314880 |
| 123 | modulation by symbiont of host immune response (GO:0052553) | 2.32314880 |
| 124 | carnitine shuttle (GO:0006853) | 2.32109853 |
| 125 | positive regulation of potassium ion transport (GO:0043268) | 2.31952846 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31685429 |
| 127 | protein localization to synapse (GO:0035418) | 2.30984779 |
| 128 | macrophage activation (GO:0042116) | 2.30492104 |
| 129 | regulation of skeletal muscle contraction (GO:0014819) | 2.29854898 |
| 130 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.29592078 |
| 131 | lysosomal transport (GO:0007041) | 2.28969385 |
| 132 | myeloid leukocyte mediated immunity (GO:0002444) | 2.28253833 |
| 133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.27297195 |
| 134 | regulation of synaptic vesicle transport (GO:1902803) | 2.27253535 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.26773645 |
| 136 | regulation of extracellular matrix organization (GO:1903053) | 2.26501762 |
| 137 | striatum development (GO:0021756) | 2.26415773 |
| 138 | sprouting angiogenesis (GO:0002040) | 2.26266698 |
| 139 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.26252772 |
| 140 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.25959309 |
| 141 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.25748658 |
| 142 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.25433879 |
| 143 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.24892256 |
| 144 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.24459174 |
| 145 | import into cell (GO:0098657) | 2.24441754 |
| 146 | female mating behavior (GO:0060180) | 2.24359560 |
| 147 | * intra-Golgi vesicle-mediated transport (GO:0006891) | 2.24274315 |
| 148 | vocalization behavior (GO:0071625) | 2.24273615 |
| 149 | early endosome to late endosome transport (GO:0045022) | 2.23968014 |
| 150 | membrane depolarization during action potential (GO:0086010) | 2.23545475 |
| 151 | vacuolar transport (GO:0007034) | 2.23519247 |
| 152 | transcytosis (GO:0045056) | 2.23516212 |
| 153 | meiotic chromosome segregation (GO:0045132) | 2.23330737 |
| 154 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.23328784 |
| 155 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.23280659 |
| 156 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.22935401 |
| 157 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.22935401 |
| 158 | growth hormone receptor signaling pathway (GO:0060396) | 2.22416271 |
| 159 | vesicle transport along microtubule (GO:0047496) | 2.22359431 |
| 160 | axonal fasciculation (GO:0007413) | 2.22223646 |
| 161 | protein localization to cilium (GO:0061512) | 2.21818666 |
| 162 | calcium ion import (GO:0070509) | 2.21767998 |
| 163 | glutamate secretion (GO:0014047) | 2.21579408 |
| 164 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.20971726 |
| 165 | detection of external biotic stimulus (GO:0098581) | 2.20847574 |
| 166 | diacylglycerol metabolic process (GO:0046339) | 2.20572566 |
| 167 | diol metabolic process (GO:0034311) | 2.19496500 |
| 168 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.19491615 |
| 169 | negative regulation of glial cell proliferation (GO:0060253) | 2.19473891 |
| 170 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.19084384 |
| 171 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.19084384 |
| 172 | L-amino acid import (GO:0043092) | 2.17618408 |
| 173 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.17589300 |
| 174 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.17523981 |
| 175 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.16595495 |
| 176 | heart trabecula formation (GO:0060347) | 2.16420367 |
| 177 | mitochondrion distribution (GO:0048311) | 2.16188218 |
| 178 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.15798586 |
| 179 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.15243362 |
| 180 | neurotransmitter secretion (GO:0007269) | 2.14866120 |
| 181 | cerebellar granule cell differentiation (GO:0021707) | 2.14421038 |
| 182 | neuron recognition (GO:0008038) | 2.14292557 |
| 183 | relaxation of muscle (GO:0090075) | 2.14152840 |
| 184 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.11655128 |
| 185 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.11565007 |
| 186 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.11395945 |
| 187 | membrane repolarization (GO:0086009) | 2.11347085 |
| 188 | axoneme assembly (GO:0035082) | 2.09419559 |
| 189 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.08820646 |
| 190 | cAMP-mediated signaling (GO:0019933) | 2.07442724 |
| 191 | response to epinephrine (GO:0071871) | 2.07158615 |
| 192 | presynaptic membrane organization (GO:0097090) | 2.07097723 |
| 193 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.06868629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.41936060 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.05036438 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79624751 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36974984 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28873236 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23753215 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19284140 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.13466590 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11914621 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.99730480 |
| 11 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.98723116 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98360354 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.98017522 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.95979840 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95761379 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94848876 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93659453 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89995337 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.89802035 |
| 20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86864001 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86746149 |
| 22 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86104050 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85206373 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84866011 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.81694905 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80662468 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79514548 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78742161 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78511024 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75870129 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75287731 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74944537 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74375667 |
| 34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.74064431 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73264098 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72144255 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70476738 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68074700 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67235194 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65377330 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64627905 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63174746 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62752556 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61899721 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61627535 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61598897 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61552984 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61552984 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61448888 |
| 50 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61019599 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60190280 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.59804261 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58470938 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56942593 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56731960 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55863638 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55401102 |
| 58 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54249054 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54151925 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52899444 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52823918 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51580061 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51158895 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50555157 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49499366 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48514882 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48362960 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46806905 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45839778 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44763079 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43964424 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43237766 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43228425 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.42976843 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42784783 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41873605 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41649157 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40545647 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39353258 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39313757 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38590770 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38323478 |
| 83 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.37358204 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35419530 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35173317 |
| 86 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.34588334 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34429250 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.34402888 |
| 89 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32934449 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32867174 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32647029 |
| 92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32327375 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31465803 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31330427 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30494228 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.30362878 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30354374 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29577357 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26976480 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26221707 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25888331 |
| 102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25251429 |
| 103 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25151727 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24546333 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24379483 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23313480 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22123455 |
| 108 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21693403 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21464752 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21374055 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21374055 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20026251 |
| 113 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19891149 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19331627 |
| 115 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18940504 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18339474 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17879832 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17207800 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16334638 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16334638 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15694149 |
| 122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13255720 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13050864 |
| 124 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12658851 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12312540 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12180720 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11600641 |
| 128 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11570580 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11035705 |
| 130 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10437015 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10173830 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10173830 |
| 133 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09841596 |
| 134 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09603633 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09427108 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08750982 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06784071 |
| 138 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06452178 |
| 139 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06357937 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06357937 |
| 141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06284309 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06101655 |
| 143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06041644 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05877038 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05614640 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05182711 |
| 147 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05182711 |
| 148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04572787 |
| 149 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04251542 |
| 150 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03720058 |
| 151 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03648049 |
| 152 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03294749 |
| 153 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02801308 |
| 154 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02737239 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02199807 |
| 156 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01977385 |
| 157 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01885763 |
| 158 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.01683628 |
| 159 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01333008 |
| 160 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00809515 |
| 161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00409277 |
| 162 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99973141 |
| 163 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99917869 |
| 164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99739947 |
| 165 | AR_19668381_ChIP-Seq_PC3_Human | 0.99136490 |
| 166 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98576254 |
| 167 | MAF_26560356_Chip-Seq_TH1_Human | 0.98483388 |
| 168 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98188786 |
| 169 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97876138 |
| 170 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97133322 |
| 171 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96695953 |
| 172 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96453765 |
| 173 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95350444 |
| 174 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95214321 |
| 175 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94428895 |
| 176 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94160562 |
| 177 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94123900 |
| 178 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93817279 |
| 179 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92483408 |
| 180 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92367768 |
| 181 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.92325914 |
| 182 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92234883 |
| 183 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92104528 |
| 184 | MYB_26560356_Chip-Seq_TH1_Human | 0.91359933 |
| 185 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90882281 |
| 186 | MAF_26560356_Chip-Seq_TH2_Human | 0.90573599 |
| 187 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90438503 |
| 188 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89587154 |
| 189 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88801309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.95419690 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.17241656 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.05027015 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.94012711 |
| 5 | MP0008260_abnormal_autophagy | 2.68387216 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.51321768 |
| 7 | MP0004147_increased_porphyrin_level | 2.51291399 |
| 8 | MP0005365_abnormal_bile_salt | 2.45488672 |
| 9 | MP0005646_abnormal_pituitary_gland | 2.43159344 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.34345580 |
| 11 | MP0003880_abnormal_central_pattern | 2.23011644 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.16947346 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.16764671 |
| 14 | MP0009840_abnormal_foam_cell | 2.16069115 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.16020027 |
| 16 | MP0002822_catalepsy | 2.14108276 |
| 17 | MP0004043_abnormal_pH_regulation | 2.13856049 |
| 18 | MP0004270_analgesia | 2.10277130 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.01318935 |
| 20 | MP0003787_abnormal_imprinting | 2.00750507 |
| 21 | MP0005083_abnormal_biliary_tract | 1.99941320 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.99798508 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 1.98965847 |
| 24 | MP0001486_abnormal_startle_reflex | 1.93066653 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.90957183 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.89899997 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.86356007 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.84978896 |
| 29 | MP0002736_abnormal_nociception_after | 1.82499257 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.76941975 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.71327896 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.70861387 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.70715093 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.70010360 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.66746623 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.65713984 |
| 37 | MP0001984_abnormal_olfaction | 1.65301019 |
| 38 | MP0003690_abnormal_glial_cell | 1.64624486 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.62314282 |
| 40 | MP0009745_abnormal_behavioral_response | 1.60717318 |
| 41 | MP0009046_muscle_twitch | 1.59025033 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.56493244 |
| 43 | MP0002009_preneoplasia | 1.55098553 |
| 44 | MP0002064_seizures | 1.52587479 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.50764459 |
| 46 | MP0002090_abnormal_vision | 1.50602451 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.49585314 |
| 48 | MP0001958_emphysema | 1.47081653 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.46807710 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.46715550 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.45411294 |
| 52 | MP0003303_peritoneal_inflammation | 1.45336123 |
| 53 | MP0002272_abnormal_nervous_system | 1.45170858 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.43642841 |
| 55 | MP0001188_hyperpigmentation | 1.42962875 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.41919706 |
| 57 | MP0005410_abnormal_fertilization | 1.41693825 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.40361249 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.38325495 |
| 60 | MP0003252_abnormal_bile_duct | 1.36913731 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.35908280 |
| 62 | MP0005409_darkened_coat_color | 1.35548338 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32541551 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.32018533 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.31023759 |
| 66 | MP0001440_abnormal_grooming_behavior | 1.30938770 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.29101396 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.28356674 |
| 69 | MP0002184_abnormal_innervation | 1.28197680 |
| 70 | MP0000778_abnormal_nervous_system | 1.28165325 |
| 71 | MP0004924_abnormal_behavior | 1.27617944 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.27617944 |
| 73 | MP0001873_stomach_inflammation | 1.26428919 |
| 74 | MP0003724_increased_susceptibility_to | 1.25894798 |
| 75 | MP0004883_abnormal_blood_vessel | 1.24883357 |
| 76 | MP0006138_congestive_heart_failure | 1.24711140 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 1.23245364 |
| 78 | MP0002971_abnormal_brown_adipose | 1.23145803 |
| 79 | MP0002269_muscular_atrophy | 1.22109200 |
| 80 | MP0003091_abnormal_cell_migration | 1.20213114 |
| 81 | MP0009115_abnormal_fat_cell | 1.19724927 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.18119577 |
| 83 | MP0005360_urolithiasis | 1.17723848 |
| 84 | MP0001661_extended_life_span | 1.17633636 |
| 85 | MP0010678_abnormal_skin_adnexa | 1.16244801 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.14966586 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 1.14237891 |
| 88 | MP0005164_abnormal_response_to | 1.14198242 |
| 89 | MP0000569_abnormal_digit_pigmentation | 1.14038944 |
| 90 | MP0003436_decreased_susceptibility_to | 1.13807459 |
| 91 | MP0003122_maternal_imprinting | 1.13478169 |
| 92 | MP0002909_abnormal_adrenal_gland | 1.13062227 |
| 93 | MP0002229_neurodegeneration | 1.11735578 |
| 94 | MP0005375_adipose_tissue_phenotype | 1.11007711 |
| 95 | MP0002419_abnormal_innate_immunity | 1.10873973 |
| 96 | MP0000371_diluted_coat_color | 1.10663551 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 1.09509391 |
| 98 | MP0008569_lethality_at_weaning | 1.07869811 |
| 99 | MP0003868_abnormal_feces_composition | 1.06635169 |
| 100 | MP0005253_abnormal_eye_physiology | 1.06616126 |
| 101 | MP0000427_abnormal_hair_cycle | 1.06321096 |
| 102 | MP0001970_abnormal_pain_threshold | 1.06320437 |
| 103 | MP0001664_abnormal_digestion | 1.05938366 |
| 104 | MP0001346_abnormal_lacrimal_gland | 1.05727958 |
| 105 | MP0004130_abnormal_muscle_cell | 1.04950896 |
| 106 | MP0002928_abnormal_bile_duct | 1.04493157 |
| 107 | MP0000383_abnormal_hair_follicle | 1.04360937 |
| 108 | MP0001177_atelectasis | 1.02632660 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 1.02516982 |
| 110 | MP0003566_abnormal_cell_adhesion | 1.02383521 |
| 111 | MP0003879_abnormal_hair_cell | 1.01831857 |
| 112 | MP0003943_abnormal_hepatobiliary_system | 1.01380541 |
| 113 | MP0006276_abnormal_autonomic_nervous | 1.00559714 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 1.00393043 |
| 115 | MP0000609_abnormal_liver_physiology | 1.00111321 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.99860924 |
| 117 | MP0000751_myopathy | 0.99855788 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.99700881 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.99536202 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.99109032 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.98704509 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.98674579 |
| 123 | MP0001501_abnormal_sleep_pattern | 0.98015437 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.97439546 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.97095165 |
| 126 | MP0004484_altered_response_of | 0.96362030 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96300150 |
| 128 | MP0004742_abnormal_vestibular_system | 0.95737617 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.95221327 |
| 130 | MP0001944_abnormal_pancreas_morphology | 0.94969926 |
| 131 | MP0002396_abnormal_hematopoietic_system | 0.93364193 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.93127449 |
| 133 | MP0002882_abnormal_neuron_morphology | 0.91974507 |
| 134 | MP0009697_abnormal_copulation | 0.91351507 |
| 135 | MP0000566_synostosis | 0.90632240 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.90532583 |
| 137 | MP0003633_abnormal_nervous_system | 0.89377474 |
| 138 | MP0002108_abnormal_muscle_morphology | 0.86682170 |
| 139 | MP0004084_abnormal_cardiac_muscle | 0.86542052 |
| 140 | MP0003045_fibrosis | 0.86379245 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.86373663 |
| 142 | MP0000747_muscle_weakness | 0.85917041 |
| 143 | MP0006054_spinal_hemorrhage | 0.85678254 |
| 144 | MP0010329_abnormal_lipoprotein_level | 0.85606155 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.85400154 |
| 146 | MP0004233_abnormal_muscle_weight | 0.85268395 |
| 147 | MP0004215_abnormal_myocardial_fiber | 0.85121787 |
| 148 | MP0001915_intracranial_hemorrhage | 0.84899433 |
| 149 | MP0000955_abnormal_spinal_cord | 0.84723334 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.84051187 |
| 151 | MP0003631_nervous_system_phenotype | 0.83473014 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.83086565 |
| 153 | MP0009384_cardiac_valve_regurgitation | 0.82560942 |
| 154 | MP0005023_abnormal_wound_healing | 0.82539511 |
| 155 | MP0004019_abnormal_vitamin_homeostasis | 0.82507821 |
| 156 | MP0002168_other_aberrant_phenotype | 0.82009502 |
| 157 | MP0005408_hypopigmentation | 0.81842861 |
| 158 | MP0005025_abnormal_response_to | 0.81458076 |
| 159 | MP0001529_abnormal_vocalization | 0.81307653 |
| 160 | MP0005171_absent_coat_pigmentation | 0.80406033 |
| 161 | MP0003329_amyloid_beta_deposits | 0.79737661 |
| 162 | MP0005330_cardiomyopathy | 0.79127469 |
| 163 | MP0004811_abnormal_neuron_physiology | 0.78974288 |
| 164 | MP0008469_abnormal_protein_level | 0.78528999 |
| 165 | MP0004087_abnormal_muscle_fiber | 0.75608259 |
| 166 | MP0005334_abnormal_fat_pad | 0.75263569 |
| 167 | MP0002078_abnormal_glucose_homeostasis | 0.75211686 |
| 168 | MP0002998_abnormal_bone_remodeling | 0.74831001 |
| 169 | MP0004381_abnormal_hair_follicle | 0.73604790 |
| 170 | MP0003195_calcinosis | 0.73590264 |
| 171 | MP0006082_CNS_inflammation | 0.71750660 |
| 172 | MP0005621_abnormal_cell_physiology | 0.71334501 |
| 173 | MP0005503_abnormal_tendon_morphology | 0.67992935 |
| 174 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67559952 |
| 175 | MP0004134_abnormal_chest_morphology | 0.67064430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe visual impairment (HP:0001141) | 4.82456951 |
| 2 | Hypoplasia of the fovea (HP:0007750) | 4.66816099 |
| 3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.66816099 |
| 4 | Albinism (HP:0001022) | 4.48721038 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.05106188 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.02138190 |
| 7 | Hyperventilation (HP:0002883) | 3.99909176 |
| 8 | Symptomatic seizures (HP:0011145) | 3.79123613 |
| 9 | Febrile seizures (HP:0002373) | 3.71951422 |
| 10 | Hypoglycemic seizures (HP:0002173) | 3.52013080 |
| 11 | Abnormality of the fovea (HP:0000493) | 3.51424812 |
| 12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.46786532 |
| 13 | Broad face (HP:0000283) | 3.38016559 |
| 14 | Central scotoma (HP:0000603) | 3.35563152 |
| 15 | Papillary thyroid carcinoma (HP:0002895) | 3.31216461 |
| 16 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.22358065 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20938712 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.20938712 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.16860537 |
| 20 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.16860537 |
| 21 | Abnormal pancreas size (HP:0012094) | 3.07918086 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02853748 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02853748 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02853748 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.92890827 |
| 26 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.91017741 |
| 27 | Deep venous thrombosis (HP:0002625) | 2.90413239 |
| 28 | Difficulty running (HP:0009046) | 2.90162832 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.89685417 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 2.89315209 |
| 31 | Focal motor seizures (HP:0011153) | 2.82161983 |
| 32 | Blue irides (HP:0000635) | 2.80007298 |
| 33 | Gait imbalance (HP:0002141) | 2.71796105 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.71190689 |
| 35 | Epileptiform EEG discharges (HP:0011182) | 2.70010401 |
| 36 | EEG with generalized epileptiform discharges (HP:0011198) | 2.69570596 |
| 37 | Atonic seizures (HP:0010819) | 2.67983396 |
| 38 | Congenital primary aphakia (HP:0007707) | 2.64447203 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.63380250 |
| 40 | Progressive hearing impairment (HP:0001730) | 2.63308302 |
| 41 | Congenital stationary night blindness (HP:0007642) | 2.61591318 |
| 42 | Hypsarrhythmia (HP:0002521) | 2.60721515 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.60208662 |
| 44 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.59405817 |
| 45 | Glomerulonephritis (HP:0000099) | 2.59200413 |
| 46 | Subacute progressive viral hepatitis (HP:0006572) | 2.56721066 |
| 47 | Prolonged QT interval (HP:0001657) | 2.53991349 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.53047013 |
| 49 | Chronic hepatic failure (HP:0100626) | 2.52157145 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.47687540 |
| 51 | Anxiety (HP:0000739) | 2.45839798 |
| 52 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45475549 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42261302 |
| 54 | Tetany (HP:0001281) | 2.40184522 |
| 55 | Hypothermia (HP:0002045) | 2.37947521 |
| 56 | Ketoacidosis (HP:0001993) | 2.36377907 |
| 57 | Focal seizures (HP:0007359) | 2.35903006 |
| 58 | Osteomalacia (HP:0002749) | 2.31977058 |
| 59 | Macroorchidism (HP:0000053) | 2.29314807 |
| 60 | Flat acetabular roof (HP:0003180) | 2.28912759 |
| 61 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.28397469 |
| 62 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.28397469 |
| 63 | Cheilitis (HP:0100825) | 2.26960693 |
| 64 | Prolonged partial thromboplastin time (HP:0003645) | 2.26786462 |
| 65 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.26660731 |
| 66 | Hemiparesis (HP:0001269) | 2.26173167 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.25612673 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.23057738 |
| 69 | Heterotopia (HP:0002282) | 2.21891995 |
| 70 | Abnormal ciliary motility (HP:0012262) | 2.20746764 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.19533982 |
| 72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.19092245 |
| 73 | Hyperphosphatemia (HP:0002905) | 2.18484559 |
| 74 | Tubulointerstitial nephritis (HP:0001970) | 2.18219577 |
| 75 | Hypoplasia of the uterus (HP:0000013) | 2.18190279 |
| 76 | Coarse hair (HP:0002208) | 2.18152494 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.17061443 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.15491373 |
| 79 | Complement deficiency (HP:0004431) | 2.11492369 |
| 80 | Agitation (HP:0000713) | 2.11308989 |
| 81 | Increased circulating renin level (HP:0000848) | 2.10843770 |
| 82 | Progressive cerebellar ataxia (HP:0002073) | 2.10294084 |
| 83 | Generalized hypopigmentation (HP:0007513) | 2.09747379 |
| 84 | Conjugated hyperbilirubinemia (HP:0002908) | 2.09552886 |
| 85 | Abnormal EKG (HP:0003115) | 2.07700124 |
| 86 | Bell-shaped thorax (HP:0001591) | 2.06613500 |
| 87 | Gaze-evoked nystagmus (HP:0000640) | 2.06348522 |
| 88 | Truncal ataxia (HP:0002078) | 2.05276039 |
| 89 | Truncus arteriosus (HP:0001660) | 2.04170983 |
| 90 | Papilledema (HP:0001085) | 2.03975875 |
| 91 | Cone-rod dystrophy (HP:0000548) | 2.03508089 |
| 92 | Drooling (HP:0002307) | 2.03118676 |
| 93 | Excessive salivation (HP:0003781) | 2.03118676 |
| 94 | Abnormality of the parathyroid morphology (HP:0011766) | 2.02084765 |
| 95 | Scotoma (HP:0000575) | 2.01341277 |
| 96 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00301725 |
| 97 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00301725 |
| 98 | Poor coordination (HP:0002370) | 1.99581883 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99407239 |
| 100 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.98769261 |
| 101 | Megalencephaly (HP:0001355) | 1.98512262 |
| 102 | Thin bony cortex (HP:0002753) | 1.97504293 |
| 103 | Nephronophthisis (HP:0000090) | 1.96517950 |
| 104 | Broad-based gait (HP:0002136) | 1.96489552 |
| 105 | Hand muscle atrophy (HP:0009130) | 1.94679757 |
| 106 | Vaginal atresia (HP:0000148) | 1.94239543 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 1.94093921 |
| 108 | Loss of speech (HP:0002371) | 1.93912576 |
| 109 | Peritonitis (HP:0002586) | 1.93721752 |
| 110 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.93537918 |
| 111 | Syncope (HP:0001279) | 1.93005137 |
| 112 | Periodontitis (HP:0000704) | 1.92747931 |
| 113 | Genital tract atresia (HP:0001827) | 1.92040972 |
| 114 | Absence seizures (HP:0002121) | 1.90715916 |
| 115 | Specific learning disability (HP:0001328) | 1.90640546 |
| 116 | Pheochromocytoma (HP:0002666) | 1.90581782 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.90277568 |
| 118 | Progressive inability to walk (HP:0002505) | 1.89052983 |
| 119 | Hyperthyroidism (HP:0000836) | 1.87103297 |
| 120 | Renal cortical cysts (HP:0000803) | 1.86853567 |
| 121 | Glucose intolerance (HP:0000833) | 1.86620789 |
| 122 | Cervical subluxation (HP:0003308) | 1.84539485 |
| 123 | Obstructive sleep apnea (HP:0002870) | 1.84375179 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84230759 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84230759 |
| 126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84230759 |
| 127 | True hermaphroditism (HP:0010459) | 1.83305696 |
| 128 | Gingivitis (HP:0000230) | 1.83176852 |
| 129 | Peripheral hypomyelination (HP:0007182) | 1.83102045 |
| 130 | Increased CSF protein (HP:0002922) | 1.82065793 |
| 131 | Abnormality of the renal medulla (HP:0100957) | 1.81236131 |
| 132 | Hemorrhage of the eye (HP:0011885) | 1.79646309 |
| 133 | Spinal canal stenosis (HP:0003416) | 1.79023973 |
| 134 | Retinitis pigmentosa (HP:0000510) | 1.77785316 |
| 135 | Upper limb amyotrophy (HP:0009129) | 1.77701327 |
| 136 | Distal upper limb amyotrophy (HP:0007149) | 1.77701327 |
| 137 | Abnormality of complement system (HP:0005339) | 1.77574887 |
| 138 | Generalized tonic-clonic seizures (HP:0002069) | 1.77220209 |
| 139 | Tibial bowing (HP:0002982) | 1.76898514 |
| 140 | Decreased lacrimation (HP:0000633) | 1.76679042 |
| 141 | Deformed sella turcica (HP:0002681) | 1.75226762 |
| 142 | Hyperglycemia (HP:0003074) | 1.74443798 |
| 143 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.74391537 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.73912378 |
| 145 | Hypoplastic nipples (HP:0002557) | 1.73785026 |
| 146 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.73699316 |
| 147 | Hypomagnesemia (HP:0002917) | 1.71301005 |
| 148 | Hip dysplasia (HP:0001385) | 1.69679803 |
| 149 | Abnormality of the renal cortex (HP:0011035) | 1.69630655 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.69397656 |
| 151 | Alacrima (HP:0000522) | 1.68347903 |
| 152 | Abnormal glucose tolerance (HP:0001952) | 1.68189416 |
| 153 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67677663 |
| 154 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.67404210 |
| 155 | Abnormality of salivation (HP:0100755) | 1.67263501 |
| 156 | Abnormality of the common coagulation pathway (HP:0010990) | 1.67219105 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66744130 |
| 158 | Severe short stature (HP:0003510) | 1.66531838 |
| 159 | Abnormality of the fingertips (HP:0001211) | 1.66018614 |
| 160 | Pigmentary retinal degeneration (HP:0001146) | 1.65569211 |
| 161 | Hypoplasia of dental enamel (HP:0006297) | 1.65172244 |
| 162 | Postaxial hand polydactyly (HP:0001162) | 1.64590067 |
| 163 | Absent eyebrow (HP:0002223) | 1.64546696 |
| 164 | Oligodactyly (hands) (HP:0001180) | 1.64444233 |
| 165 | Abolished electroretinogram (ERG) (HP:0000550) | 1.63805209 |
| 166 | Nuclear cataract (HP:0100018) | 1.63340955 |
| 167 | Flared iliac wings (HP:0002869) | 1.63230058 |
| 168 | Abnormality of macrophages (HP:0004311) | 1.63012877 |
| 169 | Ovoid vertebral bodies (HP:0003300) | 1.62714459 |
| 170 | Hyperkalemia (HP:0002153) | 1.62566985 |
| 171 | Lip pit (HP:0100267) | 1.61578089 |
| 172 | Increased IgE level (HP:0003212) | 1.61164914 |
| 173 | Hypertriglyceridemia (HP:0002155) | 1.60183230 |
| 174 | Protrusio acetabuli (HP:0003179) | 1.59400065 |
| 175 | Cupped ribs (HP:0000887) | 1.58550904 |
| 176 | Abnormal hand bone ossification (HP:0010660) | 1.58548496 |
| 177 | Proximal tubulopathy (HP:0000114) | 1.57832357 |
| 178 | Abnormal ossification of hand bones (HP:0005921) | 1.57674657 |
| 179 | Laryngomalacia (HP:0001601) | 1.57568324 |
| 180 | Abnormality of the thoracic spine (HP:0100711) | 1.56793187 |
| 181 | Generalized hyperpigmentation (HP:0007440) | 1.53992388 |
| 182 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.53753393 |
| 183 | Recurrent bacterial skin infections (HP:0005406) | 1.52635260 |
| 184 | Spondylolisthesis (HP:0003302) | 1.51124134 |
| 185 | Atelectasis (HP:0100750) | 1.50451371 |
| 186 | J-shaped sella turcica (HP:0002680) | 1.49979185 |
| 187 | Abnormality of carpal bone ossification (HP:0006257) | 1.49052427 |
| 188 | Joint hemorrhage (HP:0005261) | 1.48828378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.49161981 |
| 2 | INSRR | 3.69785107 |
| 3 | CDK12 | 3.49693292 |
| 4 | CASK | 3.16872012 |
| 5 | ERN1 | 3.16533401 |
| 6 | BRD4 | 2.81040305 |
| 7 | AKT3 | 2.62595492 |
| 8 | BLK | 2.52049584 |
| 9 | EPHB1 | 2.43892777 |
| 10 | GRK1 | 2.43588179 |
| 11 | CAMK1D | 2.39057531 |
| 12 | CAMK1G | 2.24097118 |
| 13 | SGK2 | 2.06978649 |
| 14 | RIPK4 | 2.05727218 |
| 15 | MAP3K2 | 2.01026389 |
| 16 | EPHA4 | 2.00567883 |
| 17 | NTRK3 | 1.96229128 |
| 18 | ZAP70 | 1.94940895 |
| 19 | SGK223 | 1.88341353 |
| 20 | SGK494 | 1.88341353 |
| 21 | TYK2 | 1.80208055 |
| 22 | NEK9 | 1.69864452 |
| 23 | PTK2B | 1.67721507 |
| 24 | TRIB3 | 1.60685640 |
| 25 | FGFR3 | 1.60213752 |
| 26 | SGK3 | 1.59463033 |
| 27 | MAP3K4 | 1.58839532 |
| 28 | TEC | 1.56836930 |
| 29 | NUAK1 | 1.53003974 |
| 30 | FGFR4 | 1.52493889 |
| 31 | IRAK4 | 1.52193552 |
| 32 | MAP2K7 | 1.50098470 |
| 33 | LMTK2 | 1.45418087 |
| 34 | PIK3CA | 1.44907315 |
| 35 | KSR2 | 1.39314305 |
| 36 | FRK | 1.38086813 |
| 37 | MARK2 | 1.32551762 |
| 38 | MAP3K1 | 1.30203669 |
| 39 | MAP2K3 | 1.28215190 |
| 40 | EPHA3 | 1.27330287 |
| 41 | IRAK3 | 1.24155292 |
| 42 | TNIK | 1.23450990 |
| 43 | BMX | 1.22731929 |
| 44 | MAPK13 | 1.20888643 |
| 45 | MAPK7 | 1.19874923 |
| 46 | PHKG1 | 1.15554355 |
| 47 | PHKG2 | 1.15554355 |
| 48 | PRKCE | 1.14898312 |
| 49 | CSF1R | 1.10080644 |
| 50 | PKN2 | 1.09788740 |
| 51 | PRKD2 | 1.09157285 |
| 52 | CSK | 1.06322062 |
| 53 | MET | 1.05891095 |
| 54 | MAP3K7 | 1.00617121 |
| 55 | MAP3K6 | 1.00288245 |
| 56 | MTOR | 0.98929428 |
| 57 | LATS1 | 0.98491518 |
| 58 | FER | 0.97733039 |
| 59 | MAPK12 | 0.96458968 |
| 60 | NEK6 | 0.95339830 |
| 61 | PINK1 | 0.92934328 |
| 62 | RPS6KB2 | 0.92154593 |
| 63 | STK39 | 0.91778022 |
| 64 | WNK4 | 0.91411300 |
| 65 | RIPK1 | 0.90461497 |
| 66 | PAK3 | 0.90399522 |
| 67 | RPS6KA2 | 0.89815449 |
| 68 | NTRK2 | 0.88311311 |
| 69 | SIK1 | 0.87027535 |
| 70 | PIK3CG | 0.86347235 |
| 71 | PDGFRA | 0.86145793 |
| 72 | PDK3 | 0.85821127 |
| 73 | PDK4 | 0.85821127 |
| 74 | MAPK15 | 0.85578043 |
| 75 | PDGFRB | 0.85365805 |
| 76 | EEF2K | 0.84118516 |
| 77 | TAOK3 | 0.83214332 |
| 78 | MARK1 | 0.82761508 |
| 79 | SGK1 | 0.82375559 |
| 80 | WNK1 | 0.80158925 |
| 81 | PTK2 | 0.79500558 |
| 82 | DYRK1B | 0.79473298 |
| 83 | MAPKAPK3 | 0.78484751 |
| 84 | PRKCG | 0.77928929 |
| 85 | YES1 | 0.76767636 |
| 86 | RAF1 | 0.75001223 |
| 87 | TTN | 0.74319822 |
| 88 | BMPR2 | 0.73424976 |
| 89 | MAP3K3 | 0.73302007 |
| 90 | PDK2 | 0.70932167 |
| 91 | PRKD3 | 0.69759681 |
| 92 | IRAK1 | 0.69661349 |
| 93 | ERBB3 | 0.67891832 |
| 94 | TNK2 | 0.67768169 |
| 95 | KSR1 | 0.66763964 |
| 96 | IKBKE | 0.66450733 |
| 97 | PRPF4B | 0.66335449 |
| 98 | JAK2 | 0.65924727 |
| 99 | CDK5 | 0.64936353 |
| 100 | BCR | 0.62935386 |
| 101 | MST1R | 0.62503284 |
| 102 | BMPR1B | 0.62405494 |
| 103 | MAPK10 | 0.61928808 |
| 104 | PRKD1 | 0.61494473 |
| 105 | MOS | 0.61114597 |
| 106 | WNK3 | 0.59625463 |
| 107 | CAMK4 | 0.59205461 |
| 108 | TRPM7 | 0.58992320 |
| 109 | PRKAA1 | 0.58958465 |
| 110 | ARAF | 0.58730612 |
| 111 | PRKCH | 0.56688570 |
| 112 | OXSR1 | 0.56296324 |
| 113 | TAOK1 | 0.55999715 |
| 114 | MINK1 | 0.55740636 |
| 115 | CDC42BPA | 0.54772264 |
| 116 | GRK6 | 0.54738878 |
| 117 | PTK6 | 0.54629973 |
| 118 | MAP2K4 | 0.53448153 |
| 119 | DYRK1A | 0.52800255 |
| 120 | CAMK2A | 0.52007814 |
| 121 | SIK2 | 0.51206752 |
| 122 | CAMK1 | 0.50283766 |
| 123 | TBK1 | 0.49587904 |
| 124 | PDK1 | 0.49144501 |
| 125 | CAMK2D | 0.47833770 |
| 126 | PRKAA2 | 0.47498340 |
| 127 | PRKCQ | 0.47242944 |
| 128 | IRAK2 | 0.47221514 |
| 129 | CAMK2B | 0.47094936 |
| 130 | CDK3 | 0.46040496 |
| 131 | PKN1 | 0.46026276 |
| 132 | HIPK2 | 0.45066406 |
| 133 | OBSCN | 0.42795143 |
| 134 | NTRK1 | 0.42721904 |
| 135 | RPS6KC1 | 0.41709138 |
| 136 | RPS6KL1 | 0.41709138 |
| 137 | MAPK11 | 0.39985760 |
| 138 | ICK | 0.39851562 |
| 139 | GRK7 | 0.39444588 |
| 140 | RET | 0.38482755 |
| 141 | DAPK2 | 0.38318330 |
| 142 | ZAK | 0.38262947 |
| 143 | MAPKAPK2 | 0.38155830 |
| 144 | JAK1 | 0.37734026 |
| 145 | MAP2K1 | 0.37713109 |
| 146 | MAPK8 | 0.37645823 |
| 147 | TSSK6 | 0.37645229 |
| 148 | STK38 | 0.37610405 |
| 149 | PLK2 | 0.37462734 |
| 150 | RPS6KA3 | 0.36537652 |
| 151 | PRKG1 | 0.36381986 |
| 152 | RPS6KB1 | 0.36347002 |
| 153 | PRKCB | 0.35459133 |
| 154 | DMPK | 0.35148160 |
| 155 | PRKCZ | 0.34454728 |
| 156 | PRKACA | 0.34371465 |
| 157 | MAP2K2 | 0.34030246 |
| 158 | GRK5 | 0.32046581 |
| 159 | ROCK1 | 0.31050425 |
| 160 | PDPK1 | 0.30998003 |
| 161 | CAMKK2 | 0.29730973 |
| 162 | MUSK | 0.29447061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.06407495 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.71750790 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.47973571 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.35833665 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.12840449 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95464186 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.92672132 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.89604388 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.89123317 |
| 10 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.81720132 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77698580 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.77002871 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75258540 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.73398659 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.61989413 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61978405 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.59572331 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.58763327 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.57877577 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.55236316 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53475991 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47678120 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.46887056 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46614817 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.43599082 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.42588910 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.41510101 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.40716866 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.39878189 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36985471 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.29983379 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27445059 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.27437124 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25298076 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25121450 |
| 36 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.23015009 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22167296 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.21597569 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21496756 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20445074 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19933622 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19676502 |
| 43 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.19212892 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17706632 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17499043 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17141295 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15306952 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14071394 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.12619466 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11236498 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.11183518 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08124481 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07566608 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.06886998 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06636439 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05610063 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05386592 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05002299 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04355231 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.03852971 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03285233 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 1.02835681 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01477417 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01062823 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00657685 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00194372 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00056549 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99221158 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98871784 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98591625 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97269630 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96813524 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96580139 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96450554 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95424275 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.95309341 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94899391 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94514867 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94504047 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94381642 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.94003208 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93639188 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93196356 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.92595603 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91699595 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91000739 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90926302 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90888589 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89593136 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88375696 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88170259 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88165249 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86989723 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85946658 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85820290 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85715121 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84975766 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84045673 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83119788 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82565595 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80097035 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79190466 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77685876 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77434205 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76688214 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76668866 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74482839 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73799672 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73114507 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72714466 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71006021 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70922702 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70343100 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.69792962 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.69787662 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68358112 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67368418 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66523659 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66465272 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66093190 |
| 121 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65917499 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65907123 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.65738116 |
| 124 | Hepatitis B_Homo sapiens_hsa05161 | 0.65325886 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64016241 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62416190 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61718739 |
| 128 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61172525 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60945538 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59779052 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.59747092 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.59677528 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.58983033 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58942904 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.58256415 |
| 136 | Gap junction_Homo sapiens_hsa04540 | 0.58252272 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56730004 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56491260 |
| 139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56126056 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55694022 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55557382 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55313082 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54618134 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54202943 |
| 145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53606142 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52070837 |
| 147 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51936007 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51101899 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50468593 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.50225806 |
| 151 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50151063 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.50007609 |
| 153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49856305 |
| 154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49346172 |
| 155 | Insulin resistance_Homo sapiens_hsa04931 | 0.49346023 |
| 156 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48842579 |
| 157 | Axon guidance_Homo sapiens_hsa04360 | 0.46967180 |
| 158 | Phagosome_Homo sapiens_hsa04145 | 0.46207352 |
| 159 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45377280 |
| 160 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44742214 |
| 161 | Prostate cancer_Homo sapiens_hsa05215 | 0.43579643 |
| 162 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43186532 |
| 163 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40976924 |
| 164 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40278311 |
| 165 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37511376 |

